{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:35:30Z","timestamp":1777340130612,"version":"3.51.4"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"862","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,8,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>A patient with a pituitary adenoma secreting follicle-stimulating hormone with co-existent primary hyperaldosteronism is described. After his second transsphenoidal surgery, the patient developed a Staphylococcus aureus pituitary abscess. Symptoms improved after abscess drainage. Subsequent cabergoline therapy arrested the deterioration of symptoms. and decreased serum follicle-stimulating hormone concentrations. Cabergoline may be a useful treatment for aggressively growing non-prolactin-secreting pituitary adenomas.<\/jats:p>","DOI":"10.1136\/pgmj.73.862.507","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:49:00Z","timestamp":1230587340000},"page":"507-508","source":"Crossref","is-referenced-by-count":7,"title":["Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone"],"prefix":"10.1093","volume":"73","author":[{"given":"G","family":"Leese","sequence":"first","affiliation":[{"name":"Department of Medicine, Royal Liverpool University Hospital , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Jeffreys","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Walton Hospital , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Vora","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Liverpool University Hospital , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1997,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2265.1986.tb03610.x","article-title":"Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane bound dopamine receptors which bind bromocriptine","volume":"25","author":"Bevan, J.S.; Burke, C.W.","year":"1986","unstructured":"Bevan JS, Burke CW. Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane bound dopamine receptors which bind bromocriptine. Clin Endocninol 1986; 25: 561-72.","journal-title":"Clin Endocninol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2265.1989.tb01418.x","article-title":"Bromocriptine therapy for non-functioning pituitary adenoma","volume":"30","author":"D, Van Schaardenburg; F, Roelfsema; AP, Van Seters; GJ, Vielvoye","year":"1989","unstructured":"Van Schaardenburg D, Roelfsema F, Van Seters AP, Vielvoye GJ. Bromocriptine therapy for non-functioning pituitary adenoma. Clin Endocrinol 1989; 30: 475-84.","journal-title":"Clin Endocrinol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03348493","article-title":"Medical treatment of pituitary adenomas: effects on tumour growth","volume":"8","author":"Liuzzi, A.; Chiodini, P.G.; Dallabonzana, D.; Oppizzi, G.; Verde, G.G.","year":"1985","unstructured":"Liuzzi A, Chiodini PG, Dallabonzana D, Oppizzi G, Verde GG. Medical treatment of pituitary adenomas: effects on tumour growth. (Review article) Jf Endocrinol Invest 1985; 8: 273-81.","journal-title":"(Review article) Jf Endocrinol Invest"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1984.60.1.0001","article-title":"Clinical and pathological effects of bromocriptine on prolactin secreting and other pituitary tumors","volume":"60","author":"Barrow, D.L.; Tindall, G.T.; Kovacs, K.; Thorner, M.O.; Horvath, E.; Hoffmnan, J.C.","year":"1984","unstructured":"Barrow DL, Tindall GT, Kovacs K, Thorner MO, Horvath E, Hoffmnan JC. Clinical and pathological effects of bromocriptine on prolactin secreting and other pituitary tumors. J Neurosurg 1984; 60: 1-7.","journal-title":"J Neurosurg"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2265.1985.tb03004.x","article-title":"The effect of dopamine agonist therapy on large functionless pituitary tumours","volume":"22","author":"Grossman, A.; Ross, R.; Charlesworth, M.","year":"1985","unstructured":"Grossman A, Ross R, Charlesworth M, et al. The effect of dopamine agonist therapy on large functionless pituitary tumours. Clin Endocrinol 1985; 22: 679-86.","journal-title":"Clin Endocrinol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1210\/jcem-59-6-1220","article-title":"Reduction of follicle stimulating hormone secretion in FSH-producing pituitary adenoma by bromocriptine","volume":"59","author":"Berezin, M.; Olchovsky, D.; Pines, A.; Tadmor, R.; Lunefeld, B.","year":"1984","unstructured":"Berezin M, Olchovsky D, Pines A, Tadmor R, Lunefeld B. Reduction of follicle stimulating hormone secretion in FSH-producing pituitary adenoma by bromocriptine. J Clin Endocrinol Metab 1984; 59: 1220-3.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jcem-61-3-580","article-title":"Follicle stimulating hormone and alpha subunit secreting pituitary tumor treated with bromocriptine","volume":"61","author":"Vance, M.L.; Ridgway, E.C.; Thomer, M.O.","year":"1985","unstructured":"Vance ML, Ridgway EC, Thomer MO. Follicle stimulating hormone and alpha subunit secreting pituitary tumor treated with bromocriptine. J Clin Endocrinol Metab 1985; 61: 580-4.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03350285","article-title":"Acute effects of parlodelLAR and responses to long-term treatment with bromocriptine in a patient with a follicle stimulating hormonesecreting pituitary adenoma","volume":"14","author":"Abs, R.; Parizel, P.M.; Beckers, A.","year":"1991","unstructured":"Abs R, Parizel PM, Beckers A. Acute effects of parlodelLAR and responses to long-term treatment with bromocriptine in a patient with a follicle stimulating hormonesecreting pituitary adenoma. J Endocrinol Invest 1991; 14: 135-8.","journal-title":"J Endocrinol Invest"},{"key":"ref_9","first-page":"882","article-title":"Effectiveness of cabergoline in reducing folliclestimulating hormone and prolactin hypersecretion from pituitary macroadenoma in an infertile woman","volume-title":"Fertil Steil","volume":"62","author":"Paoletti, A.M.; Depau, G.F.; Mais, V.; Guerriero, S.; Ajossa, S.; Melis, G.B.","year":"1994","unstructured":"Paoletti AM, Depau GF, Mais V, Guerriero S, Ajossa S, Melis GB. Effectiveness of cabergoline in reducing folliclestimulating hormone and prolactin hypersecretion from pituitary macroadenoma in an infertile woman. Fertil Steil 1994; 62: 882-5."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2265.1992.tb00953.x","article-title":"Long-term treatment with the dopamine agonist CV 205-502 of patients with clinically non-functioning, gonadotroph, or a-subunit secreting pituitary adenoma","volume":"36","author":"Kwekkeboom, D.J.; Lamberts, S.W.","year":"1992","unstructured":"Kwekkeboom DJ, Lamberts SW. Long-term treatment with the dopamine agonist CV 205-502 of patients with clinically non-functioning, gonadotroph, or a-subunit secreting pituitary adenoma. Clin Endocninol 1992; 36: 171-6.","journal-title":"Clin Endocninol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/73\/862\/507\/50220940\/postgradmedj-73-507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/73\/862\/507\/50220940\/postgradmedj-73-507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T06:37:44Z","timestamp":1683787064000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/73\/862\/507\/7042153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8,1]]},"references-count":10,"journal-issue":{"issue":"862","published-online":{"date-parts":[[1997,8,1]]},"published-print":{"date-parts":[[1997,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.73.862.507","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,8]]},"published":{"date-parts":[[1997,8,1]]}}}